Bernzott Capital Advisors Royalty Pharma PLC Transaction History

Bernzott Capital Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	SELL	$39.17 - $44.04 $205,955 - $231,562	-5,258 Reduced 2.91%	175,365 $0
Q3 2022 Dec 22, 2022	BUY	$39.88 - $44.65 $8,374 - $9,376	210 Added 0.12%	180,623 $7.26 Million
Q3 2022 Oct 18, 2022	BUY	$39.88 - $44.65 $7.19 Million - $8.06 Million	180,413 New	180,413 $7.25 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Bernzott Capital Advisors with notifications on news.